Cholangiocarcinoma-UK is a group affiliated to the British Association for the Study of Liver Disease (a BASL Special Interest Group).  Formed in 2018, the group’s mission statement is:

 “Cholangiocarcinoma-UK is a multi-disciplinary group of clinicians, scientists and patient advocates whose purpose is to facilitate collaborative research, enhance service development and raise the awareness of cholangiocarcinoma.”

The aims of the group are to:

  • Facilitate basic science and clinical research as well as sample collection, including for biomarker development.
  • Improve the pathway to collaborative clinical trials and opportunities for research funding
  • Update national guidelines and advise on policy and best practice
  • Optimise and standardise clinical management across the country
  • Monitor epidemiological trends accurately

To see more details about Cholangiocarcinoma-UK on BASL’s website, click here


May 2021